At a glance
ClinicalIndex Comparison RecordN/AActive· 16 enrolled
Drug / intervention
PREHABother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
In Brief
A clinical study evaluating PREHAB for Pancreas Cancer. Active but no longer recruiting, targeting 16 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreas Cancer
CountriesUnited States
Collaborators--
Timeline
N/AActive
20232024202520262027
First PostedJan 2023
Enrollment StartMay 2023
Primary CompletionOct 2025
TodayJul 2026
Study CompletionApr 2027
First PostedJan 20, 2023
Enrollment StartMay 15, 2023
Primary CompletionOct 15, 2025
Study CompletionApr 1, 2027
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 3.4 years ago
Interventions
PREHABother
6-week supervised PREHAB program. Each week of the program consists of 3 x 1 hour supervised training sessions made up of moderate intensity aerobic training and resistance training. In addition to the supervised sessions, patients will be instructed to accumulate a total of 150 minutes per week of moderate aerobic training at home which is measured by a wrist worn FitBit device.